Published onMay 13, 20242 mins readIn a $3.75 billion deal, Johnson & Johnson hopes to sell its remaining Kenvue investment.Following Johnson & Johnson's divestment of its consumer healthcare division last year and subsequent reduction of holdings in the newly formed company